Streetbeat News

Stock Prices

PTCT

The European Medicines Agency's Committee for Medicinal Products for Human Use has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of PTC Therapeutics Inc's Translarna for Duchenne muscular dystrophy. PTC plans to request a re-examination and the drug will remain on the market until the process is completed. Analysts from William Blair believe PTC has a chance to overturn the decision based on previous experience and positive data from studies.

Portfolio Pulse from Vandana Singh

September 15, 2023 | 6:05 pm

IOVA

The FDA has extended the review period for Iovance Biotherapeutics Inc's marketing application for lifileucel, a therapy for advanced melanoma. The new target action date is February 24, 2024. Despite the delay, analysts from HC Wainwright and Mizuho maintain their confidence in the approval of the therapy and reaffirm the Buy rating for IOVA stock. IOVA shares are up 18.30% at $5.49.

Portfolio Pulse from Vandana Singh

September 15, 2023 | 6:01 pm

AA

Over the past 3 months, 13 analysts have published their opinion on Alcoa (NYSE:AA) stock. The company has an average price target of $35.62, a decrease of 16.29% from the previous average price target of $42.55. The ratings range from bullish to somewhat bearish, with no bearish ratings.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

STZ

Over the past 3 months, 15 analysts have published their opinion on Constellation Brands (NYSE:STZ) stock. The average price target for the stock is $283.73, with a high of $305.00 and a low of $240.00. The average price target has increased by 6.92% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

RHP

Ryman Hospitality Props (NYSE:RHP) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 1 somewhat bearish. The company has an average 12-month price target of $111.75, which has increased by 2.52% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

RLJ

In the last quarter, RLJ Lodging (NYSE:RLJ) received 2 bullish, 1 somewhat bullish, and 3 indifferent ratings from analysts. The company's average 12-month price target is $13.33, a decrease of 4.1% from the previous average of $13.90.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

EW

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years, producing an average annual return of 19.75%. If an investor had bought $1000 of EW stock 15 years ago, it would be worth $14,652.72 today.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

BRO

In the last quarter, Brown & Brown (NYSE:BRO) received 3 bullish, 1 somewhat bullish, and 3 indifferent analyst ratings. The average 12-month price target for the company, according to 7 analysts, is $79.14, up 9.92% from the previous average of $72.00.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

CTAS

Cintas (NASDAQ:CTAS) has outperformed the market over the past 15 years, producing an average annual return of 21.19%. If an investor had bought $1000 of CTAS stock 15 years ago, it would be worth $17,195.41 today.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

PATK

Over the past 3 months, 7 analysts have published their opinion on Patrick Industries (NASDAQ:PATK) stock. The average price target is $90.86, implying an upside from the current price of $78.31. The average price target has increased by 10.04% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm